Clayton, Dubilier & Rice and GS Capital Partners, the private equity arm of Goldman Sachs, have joined to acquire HGI Holdings, a mail-order, direct-to-home provider of medical products serving chronic disease patients, for a reported $850m.
The two buyers are taking control of the company from Chicagoan private equity firm The Jordan Company and members of the Harrington family, as secondary buy-outs, where one fund sells to another, continue to dominate the dealmaking playing field.
HGI offers 30,000 products for a range of chronic disease market segments including ostomy, diabetes, urological, enteral, incontinence and wound care.
The company operates through two segments, Edgepark Medical Supplies and Independence Medical. Edgepark contracts directly with over 600 managed care organisations to provide direct-to-consumer home delivery of products to approximately 300,000 patients. Independence serves as an outsourced supply chain for approximately 5,500 commercial customers, including durable medical equipment suppliers, independent pharmacies and wholesale distributors.
“HGI is a market-leading distributor in the large and growing home health market and will continue to benefit from highly favourable long-term trends,” said Richard Schnall, a CD&R partner.
Debt financing for the transaction, expected to close in the fourth quarter, will be provided by Goldman Sachs, Jefferies & Company, Morgan Stanley and fund manager GSO Capital Partners.
Copyright © 2010 AltAssets
Article is in the following categories:
Private Equity News» By News Type» Deal News
Private Equity News» By PE Sector» Buy-out
Private Equity News» By Region» North America» United States
Private Equity News» By News Type» Deal News
Private Equity News» By PE Sector» Buy-out
Private Equity News» By Region» North America» United States








CD&R, GS Capital Partners team up for $850m healthcare buy-out